Abstract | AIM: METHODS: RESULTS: In the control group, IL-6, CRP and fibrinogen levels were significantly associated with the IL-6 -174 G/C polymorphism with a gene-dosage effect being the highest in the CC subjects and the lowest in those with the GG genotype (P<0.0001, P=0.0002 and P=0.0001, respectively). Interestingly, the CC homozygotes had lower PAI-1 levels than carriers of the G allele (P=0.04). In PAOD patients, the IL-6 -174 G/C polymorphism had no effect on all the variables measured. CONCLUSION: In contrast to apparently healthy subjects, the IL-6 -174 G/C polymorphism showed no association with plasma IL-6, CRP, fibrinogen and PAI-1 levels in PAOD patients.
|
Authors | D P Potaczek, A Undas, T Nowakowski, A Szczeklik |
Journal | International angiology : a journal of the International Union of Angiology
(Int Angiol)
Vol. 26
Issue 4
Pg. 318-23
(Dec 2007)
ISSN: 0392-9590 [Print] Italy |
PMID | 18091699
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Acute-Phase Proteins
- Blood Coagulation Factors
- Interleukin-6
|
Topics |
- Acute-Phase Proteins
(metabolism)
- Adult
- Arterial Occlusive Diseases
(blood, genetics)
- Blood Coagulation Factors
(metabolism)
- Case-Control Studies
- Female
- Genotype
- Humans
- Interleukin-6
(genetics)
- Male
- Middle Aged
- Peripheral Vascular Diseases
(blood, genetics)
- Polymorphism, Genetic
(genetics)
|